| Ytd | -30.63% | |
| 1y | -23.79% |
| Open | 4.13 | Prev Close | 4.15 | Low | 3.53 | High | 4.13 | Mkt Cap | 788.52M |
| Vol | 92.55K | Avg Vol | 55.58K | EPS | -0.05 | P/E | N/A | Forward P/E | N/A |
| Beta | 1.91 | Short Ratio | 2.72 | Inst. Own | 0.43% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 3.88 | 200-d Avg | 5.29 | 1yr Est | 0.00 |
SSII News
Company celebrated for advancing global access to its innovative robotic surgery platform Company ce
SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII)
LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on SS Innovations Intl (NASDAQ:SSII)
https://www.sec.gov/ix?doc=/Archives/edgar/data/1676163/000121390026061027/ea0291683-8k_ssinnovation
SS Innovations (NASDAQ:SSII) reported quarterly losses of $(0.02) per share. This is a 33.33 percent
SS Innovations (NASDAQ:SSII) reported quarterly losses of $(0.01) per share. This is unchanged from
SS Innovations International, Inc.
SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII)
SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII)
SS Innovations (NASDAQ:SSII) reported quarterly losses of $(0.02) per share. This is unchanged from
SS Innovations (NASDAQ:SSII) reported $10.000 million in sales this quarter. This is a 121.78 percen
Led by Dr. Mohit Bhandari, a pioneer in bariatric surgery and President of the Institute of Research
SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII)
SS Innovations (NASDAQ:SSII) reported quarterly losses of $(0.03) per share. The company reported $
SS Innovations International, Inc. (the "Company" or "SS Innovations") (NASDAQ:SSII)
Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commente